Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials
from Neurology : nature.com subject feeds https://ift.tt/AfS7N1h
In this podcast, Dr Heidi Moawad interviews a neurologist currently researching new, available treatments in headache medicine. from Front page feed http://bit.ly/2HVwnPv
Comments
Post a Comment